Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIP: Basal Insulin in Post-transplant Hyperglycemia
NCT00830297Phase 2Completed
- Start
- Jan 2009
- Primary completion
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of human insulin in hyperglycemia (2 arms). Primary endpoint: Hemoglobin A1c at 90 days. Started Jan 2009; status: completed.
02
Drugs
human insulin
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT00830297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00830297.